Copyright
©The Author(s) 2024.
World J Hepatol. Mar 27, 2024; 16(3): 418-427
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.418
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.418
Pathogen | Organs frequently affected (n) | % MDR1 |
Gram positive (n = 17) | ||
Staphylococcus aureus (n = 10) | Soft tissue infection[3], abscess[3], discitis/osteomyelitis[2], endocarditis[2] | 1/10 |
Streptococcus spp. (n = 4) | Cholangitis/cholecystitis[1], endocarditis[1], meningitis[1], epididymitis[1] | NU |
Enterococcus faecium (n = 3) | Cholangitis/cholecystitis[3] | NA |
Gram negative (n = 20) | ||
Escherichia coli (n = 7) | Cholangitis[5], soft tissue infection[2] | 6/7 |
Klebsiella spp. (n = 3) | Cholangitis[1], soft tissue infection[1], appendicitis[1] | 1/3 |
Enterobacter spp. (n = 2) | Cholangitis[1], periprothetic infection of hip joint[1] | 1/2 |
Pseudomonas spp. (n = 4) | Soft tissue infection[2], cholangitis[1], abscess[1] | 0/4 |
Campylobacter spp. (n = 3) | Colitis[3] | 0/3 |
Acinetobacter baumanii (n = 1) | Soft tissue infection[1] | 0/1 |
- Citation: Schneitler S, Schneider C, Casper M, Lammert F, Krawczyk M, Becker SL, Reichert MC. Retrospective study of the incidence, risk factors, treatment outcomes of bacterial infections at uncommon sites in cirrhotic patients. World J Hepatol 2024; 16(3): 418-427
- URL: https://www.wjgnet.com/1948-5182/full/v16/i3/418.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i3.418